160 related articles for article (PubMed ID: 29721178)
1. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma.
Audrito V; Managò A; Zamporlini F; Rulli E; Gaudino F; Madonna G; D'Atri S; Antonini Cappellini GC; Ascierto PA; Massi D; Raffaelli N; Mandalà M; Deaglio S
Oncotarget; 2018 Apr; 9(27):18997-19005. PubMed ID: 29721178
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.
Audrito V; Managò A; La Vecchia S; Zamporlini F; Vitale N; Baroni G; Cignetto S; Serra S; Bologna C; Stingi A; Arruga F; Vaisitti T; Massi D; Mandalà M; Raffaelli N; Deaglio S
J Natl Cancer Inst; 2018 Mar; 110(3):. PubMed ID: 29309612
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma.
Grolla AA; Torretta S; Gnemmi I; Amoruso A; Orsomando G; Gatti M; Caldarelli A; Lim D; Penengo L; Brunelleschi S; Genazzani AA; Travelli C
Pigment Cell Melanoma Res; 2015 Nov; 28(6):718-29. PubMed ID: 26358657
[TBL] [Abstract][Full Text] [Related]
4. Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT).
Audrito V; Managò A; Gaudino F; Deaglio S
Semin Cell Dev Biol; 2020 Feb; 98():192-201. PubMed ID: 31059816
[TBL] [Abstract][Full Text] [Related]
5. Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.
Carbone F; Liberale L; Bonaventura A; Vecchiè A; Casula M; Cea M; Monacelli F; Caffa I; Bruzzone S; Montecucco F; Nencioni A
Compr Physiol; 2017 Mar; 7(2):603-621. PubMed ID: 28333382
[TBL] [Abstract][Full Text] [Related]
6. Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties.
Audrito V; Moiso E; Ugolini F; Messana VG; Brandimarte L; Manfredonia I; Bianchi S; De Logu F; Nassini R; Szumera-Ciećkiewicz A; Taverna D; Massi D; Deaglio S
J Transl Med; 2022 Mar; 20(1):118. PubMed ID: 35272691
[TBL] [Abstract][Full Text] [Related]
7. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.
Travelli C; Colombo G; Aliotta M; Fagiani F; Fava N; De Sanctis R; Grolla AA; Garcia JGN; Clemente N; Portararo P; Costanza M; Condorelli F; Colombo MP; Sangaletti S; Genazzani AA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37880182
[TBL] [Abstract][Full Text] [Related]
8. Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target.
Sun BL; Sun X; Casanova N; Garcia AN; Oita R; Algotar AM; Camp SM; Hernon VR; Gregory T; Cress AE; Garcia JGN
EBioMedicine; 2020 Nov; 61():103059. PubMed ID: 33045468
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis.
Colombo G; Clemente N; Zito A; Bracci C; Colombo FS; Sangaletti S; Jachetti E; Ribaldone DG; Caviglia GP; Pastorelli L; De Andrea M; Naviglio S; Lucafò M; Stocco G; Grolla AA; Campolo M; Casili G; Cuzzocrea S; Esposito E; Malavasi F; Genazzani AA; Porta C; Travelli C
J Mol Med (Berl); 2020 Apr; 98(4):595-612. PubMed ID: 32338310
[TBL] [Abstract][Full Text] [Related]
10. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
Audrito V; Messana VG; Moiso E; Vitale N; Arruga F; Brandimarte L; Gaudino F; Pellegrino E; Vaisitti T; Riganti C; Piva R; Deaglio S
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33419372
[TBL] [Abstract][Full Text] [Related]
11. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5).
Torretta S; Colombo G; Travelli C; Boumya S; Lim D; Genazzani AA; Grolla AA
Cells; 2020 Feb; 9(2):. PubMed ID: 32098202
[TBL] [Abstract][Full Text] [Related]
12. Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity.
Lynn H; Sun X; Casanova NG; Bime C; Reyes Hernon V; Lanham C; Oita RC; Ramos N; Sun B; Coletta DK; Camp SM; Karnes JH; Ellis NA; Garcia JGN
Ther Adv Respir Dis; 2023; 17():17534666231181262. PubMed ID: 37477094
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice.
Yoshida M; Satoh A; Lin JB; Mills KF; Sasaki Y; Rensing N; Wong M; Apte RS; Imai SI
Cell Metab; 2019 Aug; 30(2):329-342.e5. PubMed ID: 31204283
[TBL] [Abstract][Full Text] [Related]
14. eNAMPT Is a Novel Damage-associated Molecular Pattern Protein That Contributes to the Severity of Radiation-induced Lung Fibrosis.
Garcia AN; Casanova NG; Kempf CL; Bermudez T; Valera DG; Song JH; Sun X; Cai H; Moreno-Vinasco L; Gregory T; Oita RC; Hernon VR; Camp SM; Rogers C; Kyubwa EM; Menon N; Axtelle J; Rappaport J; Bime C; Sammani S; Cress AE; Garcia JGN
Am J Respir Cell Mol Biol; 2022 May; 66(5):497-509. PubMed ID: 35167418
[TBL] [Abstract][Full Text] [Related]
15. Exercise increases the release of NAMPT in extracellular vesicles and alters NAD
Chong MC; Silva A; James PF; Wu SSX; Howitt J
Aging Cell; 2022 Jul; 21(7):e13647. PubMed ID: 35661560
[TBL] [Abstract][Full Text] [Related]
16. MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors.
Grimaldi AM; Simeone E; Festino L; Vanella V; Strudel M; Ascierto PA
Am J Clin Dermatol; 2017 Dec; 18(6):745-754. PubMed ID: 28537004
[TBL] [Abstract][Full Text] [Related]
17. Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker.
Semerena E; Nencioni A; Masternak K
Front Immunol; 2023; 14():1268756. PubMed ID: 37915565
[TBL] [Abstract][Full Text] [Related]
18. Circulating blood eNAMPT drives the circadian rhythms in locomotor activity and energy expenditure.
Park JW; Roh E; Kang GM; Gil SY; Kim HK; Lee CH; Jang WH; Park SE; Moon SY; Kim SJ; Jeong SY; Park CB; Lim HS; Oh YR; Jung HN; Kwon O; Youn BS; Son GH; Min SH; Kim MS
Nat Commun; 2023 Apr; 14(1):1994. PubMed ID: 37031230
[TBL] [Abstract][Full Text] [Related]
19. The role of MEK inhibitors in the treatment of metastatic melanoma.
Grimaldi AM; Simeone E; Ascierto PA
Curr Opin Oncol; 2014 Mar; 26(2):196-203. PubMed ID: 24419498
[TBL] [Abstract][Full Text] [Related]
20. Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody.
Quijada H; Bermudez T; Kempf CL; Valera DG; Garcia AN; Camp SM; Song JH; Franco E; Burt JK; Sun B; Mascarenhas JB; Burns K; Gaber A; Oita RC; Reyes Hernon V; Barber C; Moreno-Vinasco L; Sun X; Cress AE; Martin D; Liu Z; Desai AA; Natarajan V; Jacobson JR; Dudek SM; Bime C; Sammani S; Garcia JGN
Eur Respir J; 2021 May; 57(5):. PubMed ID: 33243842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
